Healthcare >> CEO Interviews >> July 12, 1999
PAUL A. BROWN, M.D., holds an A.B. from Harvard College and an M.D. from
Tufts University School of Medicine. From 1970 to 1984, Dr. Brown was
Chairman of the Board of MetPath Inc., a New Jersey-based corporation
offering a full range of clinical laboratory services to physicians and
hospitals, which he founded in 1967 while a resident pathologist at
Columbia Presbyterian Medical Center in New York City. MetPath developed
into the largest clinical lab in the world with over 3,000 employees and
was listed on the American Stock Exchange prior to being sold to Corning
in 1982 for $140 million. Dr. Brown is the past Chairman of the Board of
Overseers of Tufts University School of Medicine as well as an emeritus
member of the Board of Trustees of Tufts University, a member of the
Visiting Committee of the Boston University School of Medicine and a
part-time lecturer in pathology at Columbia University of Physicians and
Surgeons. Dr. Brown has served as a member of the Board of Directors of
UroCor, Inc., since 1988. Profile
your products, services, customers, those kinds of things?
Dr. Brown: Very simply, HEARx is in the business of hearing
